Cargando…

Biologic Therapies and Autoimmune Phenomena

The use of biologic medications has represented a great advancement in the treatment of autoimmune rheumatic diseases. Despite their excellent efficacy, during the last years, a growing number of reports of autoimmune phenomena and paradoxical inflammation has emerged. These phenomena may range from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drosos, Alexandros A., Pelechas, Eleftherios, Kaltsonoudis, Evripidis, Markatseli, Theodora E., Voulgari, Paraskevi V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369271/ https://www.ncbi.nlm.nih.gov/pubmed/34447904 http://dx.doi.org/10.31138/mjr.32.2.96

Ejemplares similares

The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Dermatomyositis sine myositis – Case presentation
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2017)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Treatment strategies of COVID-19: A rheumatology perspective
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Seronegative Erosive Arthritis Following SARS-CoV-2 Infection
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?
por: Drosos, Alexandros A., et al.
Publicado: (2019)

A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis
por: Drosos, Alexandros A., et al.
Publicado: (2022)

COVID-19 in patients with gout on colchicine
por: Pelechas, Eleftherios, et al.
Publicado: (2021)

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022)

A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2014)

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor
por: Pelechas, Eleftherios, et al.
Publicado: (2017)

An uncommon presentation of Granulomatosis with Polyangiitis
por: Pelechas, Eleftherios, et al.
Publicado: (2018)

A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2020)

Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry
por: Papadopoulos, Christos G, et al.
Publicado: (2019)

Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review
por: Zarkavelis, George, et al.
Publicado: (2016)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Papagoras, Charalampos, et al.
Publicado: (2009)

Fasting mimicking diets: A literature review of their impact on inflammatory arthritis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2019)

The Biological Significance of Evolution in Autoimmune Phenomena
por: Cañas, Carlos A., et al.
Publicado: (2012)

Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817)
por: Markatseli, Theodora E., et al.
Publicado: (2019)

The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis
por: Kosta, Paraskevi E, et al.
Publicado: (2011)

Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis
por: Nita, Eleni, et al.
Publicado: (2021)

Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint Diseases and a Normal Routine Workup
por: Markousis-Mavrogenis, George, et al.
Publicado: (2022)

Sjögren Syndrome Associated with Inflammatory Muscle Diseases
por: Migkos, Michail P., et al.
Publicado: (2018)

Periocular xanthogranuloma: A forgotten entity?
por: Papagoras, Charalampos, et al.
Publicado: (2010)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Rheumatological manifestations in inflammatory bowel disease
por: Voulgari, Paraskevi V.
Publicado: (2011)

Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey
por: Ermeidis, Christos, et al.
Publicado: (2023)

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Biologic therapy for autoimmune diseases: an update
por: Rosman, Ziv, et al.
Publicado: (2013)

Hysteresis phenomena in biology
por: Noori, Hamid Reza
Publicado: (2014)

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis
por: Thomas, Konstantinos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vi09gv6bffrdqkeiotff0m03rj